SLC2A3 and colorectal cancer: Recently, GLUT3 has been reported to be significantly upregulated in colorectal cancer through AMP-activated protein Kinase (AMPK) and Cyclic AMP-Responsive Element-Binding protein 1 (CREB1) signaling [34].